Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Impairment Based Treatment Versus Modified Functional Restoration Program in Chronic Low Back Pain Patients (FIRM-CLBP)

7. juli 2026 oppdatert av: Mariam Wael Mohamed, Cairo University

FIRM-CLBP: a Randomized Controlled Feasibility Trial Comparing Impairment-based Treatment With a Modified Functional Restoration Program in Older Adults With Chronic Low Back Pain

The aim of this feasibility study is to evaluate the practicality of conducting a future randomized controlled trial comparing two rehabilitation approaches for older adults with degenerative chronic low back pain: impairment-based treatment (IBT) and a modified short Functional Restoration Program (FRP).

Impairment-based treatment is an individualized approach in which interventions are tailored to the patient's specific physical deficits, such as limitations in mobility, strength, and motor control. In contrast, the Functional Restoration Program is a structured, standardized approach focusing on improving overall functional capacity through progressive exercise, movement retraining, and activity-based rehabilitation.

Participants will be randomly allocated to one of the two groups. Both interventions will be delivered by trained physiotherapists following standardized protocols over a 6-week period, with supervised sessions conducted according to a predefined rehabilitation schedule.

Studieoversikt

Studietype

Intervensjonell

Registrering (Antatt)

18

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Mariam Wael, Bachelor of physiotherapy
  • Telefonnummer: 201117614968
  • E-post: merowael14@gmail.com

Studiesteder

    • Cairo Governorate
      • Cairo, Cairo Governorate, Egypt
        • Recovery City Clinic

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • ≥ 60 years
  • Chronic Non-Specific Low Back Pain (CNSLBP)
  • Pain duration ≥ 12 weeks
  • No identifiable specific spinal pathology
  • Pain Location
  • Pain localized between the 12th rib and gluteal folds
  • With or without non-dermatomal referred pain not extending below the knee
  • Pain Intensity
  • Mean pain intensity ≥ 4/10 on the Numeric Rating Scale (NRS) over the past 7 days
  • Functional Disability
  • Oswestry Disability Index (ODI) ≥ 20% (moderate disability or higher)
  • Mechanical Pain Characteristics
  • Presence of ≥ 2 of the following:
  • Pain aggravated by movement, loading, or prolonged postures
  • Pain relieved by rest or positional change
  • Morning stiffness < 30 minutes
  • Absence of constant, non-mechanical night pain Functional Capacity
  • Able to ambulate independently (with or without assistive device)
  • Able to actively participate in an exercise-based rehabilitation program
  • Clinical Stability
  • Stable medication regimen (analgesics, anti-inflammatories, or related drugs) for ≥ 4 weeks
  • No planned changes in pharmacological treatment during the study period
  • Cognitive & Communication Ability
  • Able to understand study procedures and follow instructions
  • MMSE ≥ 24 (or equivalent cognitive screening)
  • Consent
  • Provides written informed consent

Exclusion Criteria:

  • 1. Specific Spinal Pathology ("Red Flags")

    • Suspected or confirmed:
    • Spinal fracture
    • Malignancy
    • Spinal infection
    • Inflammatory spondyloarthropathy

Clinical indicators:

Unexplained weight loss Fever or systemic illness History of significant trauma

2. Radicular or Neurological Involvement

  • Radiculopathy defined by ANY of:
  • Dermatomal pain radiating below the knee
  • Progressive motor weakness
  • Objective neurological deficit (sensory, reflex, or motor)

    3. Lumbar Spinal Stenosis (Severe)

  • Neurogenic claudication limiting walking to < 100 meters, OR
  • Symptoms not relieved by rest or flexion

    4. Prior Surgical or Structural Conditions Lumbar spine surgery within the past 12 months

    5. Medical Contraindications to Exercise

  • Severe osteoporosis with high fracture risk
  • Uncontrolled cardiovascular, respiratory, or metabolic disease
  • Any condition precluding safe participation in rehabilitation

    6. Cognitive or Behavioral Barriers

  • Severe cognitive impairment (MMSE < 24)
  • Inability to comply with study procedures

    7. Confounding Treatment Factors

  • Participation in structured physiotherapy or rehabilitation within the past 3 months
  • Planned concurrent rehabilitation during the study

    8. Psychosocial Confounders Ongoing litigation or compensation claims related to low back pain

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Enkelt

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Aktiv komparator: Impairment-based treatment group
Subgroup 1 - Lumbar Mobility Deficits Clinical characteristics Localized low back pain Restricted lumbar range of motion Segmental hypomobility Pain at end-range movement Stiffness with prolonged posture Subgroup 2 - Movement Coordination Impairment Clinical characteristics Recurrent low back pain Pain aggravated by movement Poor trunk control Difficulty maintaining neutral spine Aberrant movement patterns during functional tasks Subgroup 3 - Low Back Pain with Referred Lower Extremity Pain (Non-Radicular) Clinical characteristics Low back pain associated with referred pain to the buttock or thigh (above the knee) No neurological deficit on examination Symptoms influenced by movement or loading Mechanical pain behavior
Aktiv komparator: Modified short functional restoration program

The modified short Functional Restoration Program (FRP) is a structured, time-efficient rehabilitation approach designed to improve functional capacity in patients with chronic low back pain. It is based on a biopsychosocial model and combines progressive physical reconditioning with functional task training and patient education. The program includes aerobic conditioning, strengthening exercises, movement retraining, and graded activity exposure, with emphasis on restoring tolerance to daily activities rather than focusing solely on pain reduction.

In this modified short version, the program is adapted for older adults and delivered over a limited timeframe, with standardized session content and progression criteria to ensure consistency, safety, and feasibility within a clinical outpatient setting.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Pain intensity
Tidsramme: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
-Numerical pain rating scale (NPRS) from 1 to 10 , minimum 1 and maximum 10 . The bigger the numbers means the worse .
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
Function
Tidsramme: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)

Modified Oswestry disability Index

the MOLBPDQ consists of 10 patient-completed questions in which the response options are presented as 6-point Likert scales. Scores range from 0% (no disability) to 100% (most severe disability).

Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
Strength
Tidsramme: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
Hand held dynamometer (activ force 2)
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow up (1 month post intervention)
Eligibility rate
Tidsramme: Post intervention (week 6)

Eligibility rate will be calculated as the proportion of screened participants who meet the study eligibility criteria. All individuals assessed for participation will be recorded, including those who are eligible and those who are excluded with reasons for exclusion.

Eligibility Rate (%) = Number of Eligible Participants ÷ Number of Screened Participants × 100

Post intervention (week 6)
Retention
Tidsramme: Post intervention (week 6) Follow up (1 month post intervention)

Participant Retention Rate

Description:

Percentage of enrolled participants who complete the study through the final follow-up assessment, as determined from study participation and completion records.

Unit of Measure:

Percentage (%)

Measurement Tool:

Study participation and completion records

Post intervention (week 6) Follow up (1 month post intervention)
Intervention fidelity
Tidsramme: Post intervention (week 6)

Percentage of predefined treatment components delivered according to the study protocol, as assessed using a standardized intervention fidelity checklist completed by an independent assessor during treatment sessions. Fidelity scores will be calculated as the proportion of protocol-required components successfully delivered.

Unit of Measure:

Percentage (%)

Measurement Tool:

Standardized Intervention Fidelity Checklist

Post intervention (week 6)
Recruitment feasibility
Tidsramme: Post intervention (weak 6)
Determine the recruitment rate (number of eligible and consenting participants per month) among older adults with degenerative chronic low back pain recruited from the clinical setting
Post intervention (weak 6)
Safety outcome
Tidsramme: every session
The incidence, type, severity, and relatedness of any adverse events or undesirable effects potentially attributable to the rehabilitation intervention will be monitored and documented throughout the study period. Adverse events may include increased pain, excessive fatigue, symptom aggravation, dizziness, discomfort during or after treatment, or any other unexpected clinical complaint reported by the participant or observed by the therapist.
every session
Data completeness
Tidsramme: Baseline (week zero) post-intervention: Week 6 Follow-up: 1 month post-intervention
Data completeness will be assessed by calculating the proportion of completed outcome assessments at each assessment point out of the total expected outcome assessments. Missing or incomplete data will be recorded and reported.
Baseline (week zero) post-intervention: Week 6 Follow-up: 1 month post-intervention

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Adherence
Tidsramme: Post intervention (week 6)

Participant adherence will be assessed throughout the intervention period using session attendance records, completion of the prescribed exercise program, and therapist documentation. Attendance adherence will be calculated as the percentage of attended treatment sessions out of the total scheduled sessions. Home exercise adherence will be monitored using a patient exercise diary or checklist, where participants record the frequency of performed exercises. Overall adherence will be considered acceptable when the participant completes at least 80% of the scheduled sessions and prescribed home exercises.

Adherence rate will be calculated using the following formula:

Adherence Rate (%) = Number of Completed Sessions or Exercises ÷ Total Prescribed Sessions or Exercises × 100

Post intervention (week 6)
Quality of Life outcome
Tidsramme: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow-up (1 month post-intervention)
Short Form 12 Item Health Survey Sf-12 , when the score gets higher it means better outcome.
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (week 6) Follow-up (1 month post-intervention)
Range of motion
Tidsramme: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
Goniometer
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
Pressure pain threshold
Tidsramme: Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
Pressure pain threshold will be measured by pressure algometer using Kilogram as a unit of measurement.
Baseline (week =zero) Intervention Mid Intervention (week 2) Post intervention (weak 6) Follow up (1 month post intervention)
Acceptability
Tidsramme: Post-intervention: Week 6 Follow-up: 1 month post-intervention
Acceptability will be assessed using participant feedback regarding the practicality, ease of use, burden, and overall acceptability of the study procedures and measurement tools. Feedback may be collected using a brief questionnaire, rating scale, or structured interview.
Post-intervention: Week 6 Follow-up: 1 month post-intervention

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Antatt)

1. juli 2026

Primær fullføring (Antatt)

1. november 2026

Studiet fullført (Antatt)

10. januar 2027

Datoer for studieregistrering

Først innsendt

28. april 2026

Først innsendt som oppfylte QC-kriteriene

7. juli 2026

Først lagt ut (Faktiske)

13. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

13. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

7. juli 2026

Sist bekreftet

1. juli 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • FIRM-CLBPstudy

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere